Abstract
Oncogenic activation of c-myb by retroviral insertion has been implicated in tumor formation in chicken and mice. These genetic alterations result in deregulated expression of the c-myb gene and frequently in N-terminal truncation of the c-Myb protein. We demonstrate that truncation of the c-Myb N-terminus affects DNA binding and reporter activation. However, all three mutants, MybΔN20, MybΔN47 and MybΔN71 cooperated with C/EBPβ in reporter assays. In contrast to MybΔN20 and MybΔN47, however, the MybΔN71 mutant failed to activate the chromatin embedded endogenous mim-1 gene together with C/EBPβ. This suggests that an N-terminal region (amino acids 47–71) within repeat 1 (R1) of the murine c-Myb DNA binding domain affects activation of chromosomal target genes in collaboration with C/EBPβ.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Brendeford EM, Myrset AH, Hegvold AB, Lundin M, Gabrielsen OS . 1997 J. Biol. Chem. 272: 4436–4443
Burk O, Mink S, Ringwald M, Klempnauer K-H . 1993 EMBO J. 12: 2027–2038
Dash AB, Orrico FC, Ness SA . 1996 Genes and Dev. 10: 1858–1869
Dini PW, Lipsick JS . 1993 Mol. Cell. Biol. 13: 7334–7348
Dini PW, Eltman JT, Lipsick JS . 1995 J. Virol. 69: 2515–2524
Ebneth A, Adermann K, Wolfes H . 1994 FEBS Lett. 337: 265–268
Ganter B, Lipsick JS . 1999 Adv. Cancer Res. 76: 21–60
Introna M, Golay J, Frampton J, Nakano T, Ness SA, Graf T . 1990 Cell 63: 1289–1297
Jiang W, Kanter MR, Dunkel I, Ramsay RG, Beemon KL, Hayward WS . 1997 J. Virol. 71: 6526–6533
Kanter MR, Smith RE, Hayward WS . 1988 J. Virol. 62: 1423–1432
Katz S, Kowenz-Leutz E, Müller C, Meese K, Ness SA, Leutz A . 1993 EMBO J. 12: 1321–1332
Kowenz-Leutz E, Leutz A . 1999 Mol. Cell 4: 735–743
Kowenz-Leutz E, Herr P, Niss K, Leutz A . 1997 Cell 91: 185–195
Kowenz-Leutz E, Twamley G, Ansieau S, Leutz A . 1994 Genes and Dev. 8: 2781–2791
Kozak M . 1991 J. Cell Biol. 115: 887–903
Krieg J, Oelgeschläger M, Janknecht R, Lüscher B . 1995 Oncogene 10: 2221–2228
Lüscher B, Christenson E, Litchfield DW, Krebs EG, Eisenman RN . 1990 Nature 344: 517–522
Mink S, Haenig B, Klempnauer K-H . 1997 Mol. Cell. Biol. 17: 6609–6617
Mukhopadhyaya R, Wolff L . 1992 J. Virol. 66: 6035–6044
Nakano T, Graf T . 1992 Oncogene 7: 527–534
Nazarov V, Wolff L . 1995 J. Virol. 69: 3885–3888
Ness SA . 1996 Biochim. Biophys. Acta 1288: F123–F139
Ness SA, Kowenz-Leutz E, Casini T, Graf T, Leutz A . 1993 Genes and Dev. 7: 749–759
Ness SA, Marknell A, Graf T . 1989 Cell 59: 1115–1125
Nomura T, Sakai N, Sarai A, Sudo T, Kanei-Ishii C, Ramsay RG, Favier D, Gonda TJ, Ishii S . 1993 J. Biol. Chem. 268: 21914–21923
Oelgeschläger M, Janknecht R, Krieg J, Schreek S, Lüscher B . 1996 EMBO J. 15: 2771–2780
Oelgeschläger M, Krieg J, Lüscher-Firzlaff JM, Lüscher B . 1995 Mol. Cell. Biol. 15: 5966–5974
Ording E, Kvåvik W, Bostad A, Gabrielsen OS . 1994 Eur. J. Biochem. 222: 113–120
Pizer E, Baba TW, Humphries EH . 1992 J. Virol. 66: 512–523
Pizer E, Humphries EH . 1989 J. Virol. 63: 1630–1640
Saikumar P, Murali R, Reddy EP . 1990 Proc. Natl. Acad. Sci. USA 87: 8452–8459
Shen-Ong GLC, Wolff L . 1987 J. Virol. 61: 3721–3725
Tanikawa J, Yasukawa T, Enari M, Ogata K, Nishimura Y, Ishii S, Sarai A . 1993 Proc. Natl. Acad. Sci. USA 90: 9320–9324
Wolff L . 1996 Crit. Rev. Oncog. 7: 245–260
Wolff L, Koller R, Davidson W . 1991 J. Virol. 65: 3607–3616
Acknowledgements
We thank L Wolff and M Austen for providing reagents. This work was supported by grants from the DFG (Lu 466/1-4) and the Fonds der Chemischen Industrie to B Lüscher.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Oelgeschläger, M., Kowenz-Leutz, E., Schreek, S. et al. Tumorigenic N-terminal deletions of c-Myb modulate DNA binding, transactivation, and cooperativity with C/EBP. Oncogene 20, 7420–7424 (2001). https://doi.org/10.1038/sj.onc.1204922
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1204922
Keywords
This article is cited by
-
MYB oncoproteins: emerging players and potential therapeutic targets in human cancer
Oncogenesis (2021)
-
MYB function in normal and cancer cells
Nature Reviews Cancer (2008)